Skip to main content
  • 19 Accesses

Zusammenfassung

In der Klinik besitzen die ACE-Hemmer einen festen Stellenwert bei der Therapie der Hypertonie und der Herzinsuffizienz. Für die Indikation bei der Herzinsuffizienz war die Consensus-Studie richtungsweisend. Nach der CAST-Studie erfuhr die Therapie mit Antiarrhythmika bei Patienten nach manifestem Herzinfarkt eine kritische Wertung.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Becker H (1980) Ruhe-EKG, Speicher-EKG und Mechanokardiographie: In: Kaltenbach M, Roskamm H (Hrsg) Vom Belastungs-EKG zur Koronarangiographie. Springer, Berlin Heidelberg New York, S 17–31

    Google Scholar 

  2. Bigger JT (1987) Why patients with congestive heart failure die: arrhythmias and sudden cardiac death. Circulât Vol 75, Supp IV 28–35

    Google Scholar 

  3. Bounhoure JP, Kayanakis JG, Fauvel JM, Puel J (1982) Beneficial effects of Captopril in left ventricular failure in patients with myocardial infarction. Br J Clin Pharmacol (Suppl 2 ) 14: 187–191

    Google Scholar 

  4. Bussmann WD (1984) Akute und chronische Herzinsuffizienz. Springer Berlin Heidelberg New York, S 264–277

    Google Scholar 

  5. Chatterjee K, Rouleau JL, Parmley W (1982) Hemodynamic and myocardial metabolic effects of Captopril in chronic heart failure. Br Heart J 47: 233–228

    Article  PubMed  CAS  Google Scholar 

  6. Cleland JGF, Dargie HJ, Hodsman GP, Ball SG, Robertson JIS, Morton JJ, East BW, Robertson I, Murray GD, Gillen G (1984) Captopril in heart failure. A double-blind controlled trial. Br Heart J 54: 305–312

    Article  Google Scholar 

  7. Cleland JGF, Dargie HJ, Ball SG, Gillen G, Hodsman GP, Morton JJ, East BW, Robertson I, Ford I, Robertson JIS (1985) Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones and metabolic state. Br Heart J 6: 305–312

    Article  Google Scholar 

  8. Consensus Trial Group (1987) Effects of enalapril on mortality in severe congestive heart failure. New Engl J Med 316: 1429–1435

    Article  Google Scholar 

  9. Daly P, Mettauer B, Cousineau D, Burgess JJ (1985) Lack of reflex increases im myocardial sypathetic tone after Captopril: potential antianginal effect. Circulation 71 /2: 317–325

    Article  PubMed  CAS  Google Scholar 

  10. Ertl G, Kloner RA, Alexander RW, Braunwald E (1982) Limitation of experimental infarct size by angiotensin-converting enzyme inhibitor. Circulation 65: 40–48

    Article  PubMed  CAS  Google Scholar 

  11. Grossmann A, Eckland D, Price P, Edwards CRW (1980) Captopril Reversal renal failure with severe hyperkaliämie. Lancet I: 712

    Google Scholar 

  12. Linz W, Schölkens BA (1987) Influence of local converting enzyme inhibition of angiotensin and bradykinin effects in ischemic rat hearts. J Cardiovasc Pharmacol 10: 75–82

    Article  Google Scholar 

  13. Mettauer B, Rouleau JL, Daly P (1986) The effect of Captopril on the coronary circulation and myocardial metabolism of patients with coronary artery disease. Postgrad Med J 62: 54–58

    PubMed  Google Scholar 

  14. Packer M (1985) Sudden unexpected death in patients with congestive heart failure: a second frontier. Brit Heart J 72: 681–685

    CAS  Google Scholar 

  15. Packer M, Hung Lee W, Yushar M, Medina N (1986) Comparison of Captopril and enalapril in patients with severe chronic congestive heart failure. New Engl J Med, Vol. 315, 14, 847–853

    Article  PubMed  CAS  Google Scholar 

  16. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P (1985) Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with Captopril. Circulation 72: 406–412

    Article  PubMed  CAS  Google Scholar 

  17. Strozzi C, Cocco G, Porta Luppi F, Urso L, Alfiero R, Tasini MT, Montanari L, Yassini KA, Rizzo A (1987) Effects of Captopril on the physical work capacity of normotensive patients with stable effort angina pectoris. Cardiology 74: 226–228

    Article  PubMed  CAS  Google Scholar 

  18. Webster MWI, Fitzpatrick A, Nicholls G, Ikram H, Isells E (1985): Effect of enalapril on ventricular arrhythmias in congestive heart failure. Am J Cardiol 56: 56–569

    Article  Google Scholar 

  19. Van Zwieten PA, van Meel JCA, de Jonge A, Kalkman PB, Timmermanns MWM (1982) Zur Pharmakologie vasodilatatorisch wirksamer Pharmaka; neuere Entwicklungen. Dtsch Ges Herz Kreislaufforsch 48: 78–86

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Dr. Dietrich Steinkopff Verlag, GmbH Co. KG, Darmstadt

About this paper

Cite this paper

Graf, B. (1991). Therapie mit ACE-Hemmern. In: Schmidt, G. (eds) Medikamentöse Behandlung des Postinfarktpatienten nach CAST. Steinkopff. https://doi.org/10.1007/978-3-642-85414-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85414-9_12

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-85415-6

  • Online ISBN: 978-3-642-85414-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics